Define, shape and create successful global patent litigation strategies, mitigate risk and remain competitive on the global stage. This industry-driven event will provide insights on the latest life science litigation, including cross-border cases, biosimilars, vaccines, and SPCs. The focus? To provide the latest insights into patent litigation while staying updated on legal developments. Over the two days discussions will identify cutting edge-trends in European patent litigation and beyond.
The main conference running from 21st - 22nd January will examine the latest global and European litigation updates, risk mitigation strategies, and how to devise a cost-effective IP litigation strategy.
On the 20 January, the pre-event delivers the UPC Litigation Forum, this cross-industry event brings together top in-house counsels, private practice litigators, regulators, and judges to discuss the latest procedural updates and case law from the UPC.
Access to this event is included.
With an array of speakers, including Judges from the UPC, law firms and a wide range of pharma and biotech companies, we are delighted to have our own specialists participating in key sessions. Partner (UK), Mike Gilbert, will sit on an industry-led panel session ‘Global biosimilar molecule patent litigation and launch review' and Partner and Co-Head of Litigation in Canada, Kamleh J. Nicola, will host the ‘Regulatory Data Exclusivity: Global Litigation Strategies’ global roundtable.
Join us for an in-depth exploration of critical issues and winning strategies in pharma and biotech patent litigation. This must-attend event connects you with industry leaders and innovators actively shaping the landscape. Network with key players and gain insights to stay ahead of the curve.
Specialists
on the ground in Amsterdam
Mike is an IP lawyer who advises clients in a wide variety of business sectors on issues including litigation and dispute resolution, IP strategy and risk limitation, due diligence projects and commercial and licensing transactions involving IP.
Kamleh J. Nicola
Partner | Co-Head of Litigation | Barrister and Solicitor
Co-Head of Litigation | Barrister and Solicitor
Kamleh Nicola is a partner at Marks & Clerk and Co-Head of the firm’s Litigation practice in Canada.
Dan is a Managing Associate who advises clients on a wide range of intellectual property issues, with a focus on contentious life sciences and high-tech work. He has particular experience in biopharmaceutical patent and SPC litigation and has represented clients in some of the most complex technical disputes tried in the English courts.
Leading Life Science Experts
At Marks & Clerk, you work with experts, whose technical and legal capabilities are accurately matched to your needs.
Upcoming events
Scotland’s Life Sciences Conference & Awards Dinner
This conference will focus on two key themes: Venture Capital and Investor Funding, and Regulatory Challenges faced by the Life Sciences industry.
Read more
IBioIC’s 11th Annual Conference
IBioIC25 will be our 11th Annual Conference. This not-for-profit conference is the industry event of the year for the industrial biotechnology community in Scotland, and one of the pre-eminent events in the global biotech calendar.
Read more
WTR Live: Brand Strategy Summit Europe 2025
WTR Live: Brand Strategy Summit Europe is returning to London on 5 and 6 March to unite senior brand leaders, in-house trademark professionals, policy makers and their trusted legal advisers.
Read more